No Prescription |
 |
 | ||
|
BUDENASE AQ Rhinocort |
|
| ||
No Prescription » Prescription Drugs 3 » BUDENASE AQ Rhinocort This medication is used to treat nasal symptoms (sneezing itching runny/stuffy nose) caused by allergies. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.How to use Budesonide NaslRead the Patient Information Leaflet provided by your pharmacist before you start using budesonide and each time you get a refill. If you have any questions consult your doctor or pharmacist.Shake the container gently and remove the protective cap before each use. Follow the instructions on how to properly prime the bottle if you are using it for the first time or if you have not used it for 2 or more days. Follow the instructions for cleaning the applicator if you have not used the medication for 14 or more days.Gently blow your nose before using this drug. Insert the spray tip into your nostril. Close the other nostril with a finger and lean your head slightly forward. Spray into the nostril usually once daily or as directed by your doctor. After spraying lean your head backward for a few seconds. If more sprays are prescribed repeat in the same nostril. Then repeat for the other nostril if so directed. Avoid blowing your nose for 15 minutes after using the medication. Avoid spraying the medication into your eyes or onto the middle of the inside of your nose (nasal septum).After each use wipe the spray tip with a clean tissue and replace the protective cap. If the spray tip becomes blocked do not try to unblock the nasal applicator by using a sharp object. Look at the instructions on regular cleaning of the spray bottle.Use this medication regularly in order to get the most benefit from it. This medication works best if used at even intervals. To help you remember use it at the same time each day. Do not increase your dose use this more frequently or stop using this medication without first consulting your doctor. Dosage is based on your age medical condition and response to therapy. Your doctor may lower your dose once you have had a response to the medication. Follow your doctor's instructions carefully.This medication does not work immediately. Some people will feel this medication working within 2 days but it may take up to 2 weeks before the full benefit of this drug takes effect.Keep track of the number of sprays used from each container. Discard the container after you have used the number of sprays noted on the package. Do not pour any remaining medication into another container.Inform your doctor if your condition persists or worsens after 2 weeks of use. Buy BUDENASE AQ Rhinocort and other Prescription Drugs 3 products online at Medstore. 418
About BUDENASE AQ Rhinocort: Product Type: Prescription Drugs 3 BUDENASE AQ ( Rhinocort Generic Budesonide ) BUDENASE AQ (Rhinocort Generic Budesonide) Rhinocort Generic Budesonide 100mcgAqu Nasal spray 150 MDI Rhinocort Generic Budesonide BUDENASE AQ
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
